// App-Quantinova.ai

P2-01-01 : Establishment and Validation of Circulating Tumor Cell-Based Prognostic Nomograms in 497 First-Line Metastatic Breast Cancer Patients

Researchers

Presenter

  • Giordano A

Principal Investigators

  • Reuben JM

  • Egleston BL

  • Hajage D

  • Hortobagyi GN

  • Cristofanilli M

  • Pierga J-Y

  • Bidard F-C

Medical Centers

  • Institut Curie, Paris Cedex, France

  • Fox Chase Cancer Center, Philadelphia, PA

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

Locations

  • France

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Bone metastases

  • Solid malignancies

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved